A

A

USD

Agilent Technologies Inc. Common Stock

$108.630-0.610 (-0.558%)

Real-time Price

Healthcare
Diagnostics & Research
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$109.240

High

$110.280

Low

$107.450

Volume

0.17M

Company Fundamentals

Market Cap

31.0B

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

2.13M

Exchange

NYQ

Currency

USD

52-Week Range

Low $96.43Current $108.630High $155.35

AI Analysis Report

Last updated: Apr 30, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

Agilent Technologies Inc. Common Stock (A): Analyzing Recent Moves & What Might Come Next

Stock Symbol: A Generate Date: 2025-04-30 16:32:15

Alright, let's break down what's been happening with Agilent Technologies stock lately. Think of this as looking under the hood to see what might be driving things and what to keep an eye on.

Recent News Buzz: A Mixed Bag

Looking at the headlines from the past few weeks, it's a bit of a mixed picture for Agilent.

On the positive side, there was news about a joint venture Agilent is involved in, Smackover Lithium. Their project in Arkansas got a thumbs-up from regulators and even received a special designation from the government. That sounds like good progress for that specific venture. Agilent also highlighted its work in cancer research at a big conference, which is right in line with their main business in diagnostics and life sciences.

But here's where things get a little less sunny: several Wall Street analysts have recently lowered their price targets for Agilent's stock. We saw Jefferies, Wells Fargo, and Barclays all trim where they think the stock price is headed. Even if some still rate it a "Hold" or "Overweight," cutting the target price usually signals they see less potential upside than before. That's definitely something investors notice.

There was also some news about tariffs impacting aerospace suppliers (Boeing, RTX, GE), but that seems pretty far removed from what Agilent does, so it's probably not a major factor here.

So, the news vibe is positive on specific projects and core business showcase, but tempered by analysts dialing back their expectations on the stock's value.

Price Check: A Rocky Ride, Then a Pause

Now, let's look at the stock chart over the last three months or so. It hasn't been a smooth ride. The price took a pretty significant tumble from the $140s and $150s back in January/February, hitting a low point around $96 in early April.

Since hitting those lows, the stock has bounced back somewhat and seems to be trading in a tighter range, mostly between $100 and $108 through April. The price closed recently around $105.81. So, it's recovered a bit from the bottom, but it's still way down from where it was earlier in the year. It looks like it's trying to find its footing after that big drop.

Putting It Together: What Might Be Next?

Okay, so we have mixed news (analyst caution vs. project progress), a stock price that fell hard and is now consolidating, and an AI prediction.

The AI model is actually predicting some short-term upward movement from here – around 1% today, 2% tomorrow, and 2.6% the day after. It also flags some technical signals suggesting bullish momentum and buying pressure, even noting the price is near a support level around $106.31 which it sees as a potential buying spot. The AI's overall recommendation score leans bullish, partly based on its own sentiment analysis (though, as we saw, the raw news about analyst targets is a counterpoint).

Given all this, the picture is a bit complex. The analyst target cuts are a clear headwind, suggesting potential resistance or limited upside in the medium term. However, the AI's prediction and some technical signs point to a possibility of the stock continuing its recent bounce or holding steady with a slight upward bias in the very near term.

Potential Outlook: Based on the AI's short-term bullish forecast and the price stabilizing after its drop, there might be room for a little more upside in the immediate future, perhaps continuing the April trend. But the analyst downgrades are a big yellow flag for anyone thinking longer term.

Strategy Ideas (Thinking Out Loud):

  • If you're already holding, the current price is well above the recent lows, which is good. The AI suggests potential for a bit more gain in the next few days.
  • For someone looking to potentially get in for a short-term trade, the AI's suggested entry points around the current price ($106.42, $107.02) align with the idea that the stock might push a little higher from here.
  • Managing risk is key. The AI suggests a stop-loss around $96.16. This is below the recent lows, which makes sense as a level where the recent recovery trend would be broken.
  • For taking profits, the AI's short-term target is $113.51. This is above the recent April trading range and could be a level to watch if the stock does move up. Remember, this is much lower than the AI's longer-term potential target of $150.91 or even the old analyst targets, which highlights the current uncertainty.

Keep in mind that Agilent is primarily a healthcare company focused on diagnostics and research tools. While the lithium JV is interesting, their core business performance and the upcoming earnings report (scheduled for May 28th) will likely be the biggest drivers of the stock price over time. The analyst target cuts might be related to expectations for that core business.

Important Disclaimer

Please remember, this analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and predictions are never guaranteed. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Related News

GlobeNewswire

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission

LEWISVILLE, Ark., April 24, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a Joint Venture ("JV") between Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLI) (NYSE:A) and Equinor, is pleased to announce

View more
Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission
BusinessWire

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

Agilent Technologies Inc. (NYSE:A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products and

View more
Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
CNBC

Boeing reports results before the bell. Here's what to expect

Boeing hasn't reported an annual profit since 2018.

View more
Boeing reports results before the bell. Here's what to expect
CNBC

RTX, GE Aerospace expect more than $1 billion tariff impact

Aerospace suppliers are grappling with higher prices for parts from President Donald Trump's tariffs.

View more
RTX, GE Aerospace expect more than $1 billion tariff impact
GlobeNewswire

Smackover Lithium's South West Arkansas Project Receives Special Designation as a Priority Transparency Critical Mineral Project From the Trump Administration

LEWISVILLE, Ark., April 21, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a Joint Venture ("JV") between Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLI) (NYSE:A) and Equinor, is proud to announce

View more
Smackover Lithium's South West Arkansas Project Receives Special Designation as a Priority Transparency Critical Mineral Project From the Trump Administration
Analyst Upgrades

Jefferies Maintains Hold on Agilent Technologies, Lowers Price Target to $116

Jefferies analyst Brandon Couillard maintains Agilent Technologies with a Hold and lowers the price target from $135 to $116.

Analyst Upgrades

Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $135

Wells Fargo analyst Brandon Couillard maintains Agilent Technologies with a Overweight and lowers the price target from $155 to $135.

AI PredictionBeta

AI Recommendation

Bullish

Updated at: May 3, 2025, 10:20 AM

BearishNeutralBullish

70.3% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Conservative
Trading Guide

Entry Point

$108.50

Take Profit

$110.75

Stop Loss

$97.72

Key Factors

PDI 4.9 is above MDI 4.6 with ADX 11.3, suggesting bullish trend
Current Price is extremely close to support level ($108.43), suggesting strong buying opportunity
Trading volume is 4.7x average (22,234), indicating extremely strong buying pressure
MACD 0.0581 is above signal line 0.0439, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.